NCCR-Synapsy

The Synaptic Bases of Mental Diseases

KTT

KTT (Knowledge & Technology Transfer)​

KTT is applied to all innovative research that has potential for further technological development and exploitation. These types of research projects need to be identified early in order for the intellectual property to be protected by patents, copyrights or licensing agreements.

In 2017,  Synapsy researchers made five invention announcements and created a start-up biotech company (GliaPharm).

Sylvain Lengacher portrait

Synapsy KTT Officer
Dr. Sylvain Lengacher
Campus Biotech
Ch. des Mines 9
1202 Genève
+41 22 545 11 15
sylvain.lengacher@unige.ch

PARTNERS' KTT DEPARTMENTS

logo epfl 2019

EPFL-TTO

Station 10
CH-1015 Lausanne
+41 21 693 70 23
infoSRI@epfl.ch

pactt logo

PACTT

Rue du Bugnon 21
CH-1011 Lausanne
+41 21 314 59 72
pactt.info@chuv.ch

unitec logo

UNITEC

Université de Genève
28, bd du Pont-d’Arve
CH-1205 Genève
+41 22 379 03 50
unitec@unige.ch

unitectra logo

UNITECTRA (Büro Basel)

Schützenstrasse 16
CH-4051 Basel
+41 61 267 30 14
mail@unitectra.ch

DATA MANAGEMENT PLAN (DMP)

Lebrand Presentation
(pdf 5MB – pw protected)

Hagmann Presentation
(pdf 1MB – pw protected)

Lengacher Presentation
(pdf 2MB – pw protected)